-
Advertorial
-
FOCUS
-
Guide
-
Lifestyle
-
Tech and Vogue
-
TechandScience
-
CHTF Special
-
Nanhan
-
Futian Today
-
Hit Bravo
-
Special Report
-
Junior Journalist Program
-
World Economy
-
Opinion
-
Diversions
-
Hotels
-
Movies
-
People
-
Person of the week
-
Weekend
-
Photo Highlights
-
Currency Focus
-
Kaleidoscope
-
Tech and Science
-
News Picks
-
Yes Teens
-
Fun
-
Budding Writers
-
Campus
-
Glamour
-
News
-
Digital Paper
-
Food drink
-
Majors_Forum
-
Speak Shenzhen
-
Business_Markets
-
Shopping
-
Travel
-
Restaurants
-
Hotels
-
Investment
-
Yearend Review
-
In depth
-
Leisure Highlights
-
Sports
-
World
-
QINGDAO TODAY
-
Entertainment
-
Business
-
Markets
-
Culture
-
China
-
Shenzhen
-
Important news
在线翻译:
szdaily -> In depth
Experts call for increased efforts to develop new cancer-related medicine
    2018-February-6  08:53    Shenzhen Daily

MEDICAL experts called for increased efforts to develop cancer-related medicine and improve the availability of new drugs in China during the 19th World Cancer Day observed Sunday.

The five-year survival rate for patients with cancer in the United States has increased by 41 percent since 1975 thanks to new therapies, including the use of new drugs, according to a report issued by the drug research and development committee of the China Association of Enterprises with Foreign Investment.

It said that the 83-percent increase in lifespan was attributed to the use of new therapies.

However, the availability of new drugs in China falls behind some developed countries, it said. Only six of 49 types of new drugs were available in China between 2010 and 2014.

Shen Lin, deputy head of Beijing Cancer Hospital, said at the publication ceremony for the report that there has been no effective chemotherapy medicine to treat esophageal cancer in more than 30 years in China.

Zhao Yan, deputy president of the oncology medical department of Novartis China, called for joint efforts by governments, pharmaceutical companies and hospitals to develop new drugs.

China has taken measures to improve the availability of new cancer-related drugs over the past two years.

(Xinhua)

 

深圳报业集团版权所有, 未经授权禁止复制; Copyright 2010, All Rights Reserved.
Shenzhen Daily E-mail:szdaily@szszd.com.cn